Loading organizations...
Loading organizations...
Developing next-generation therapeutic vaccines for cancer and infections.
Bellicum Pharmaceuticals has raised $94.2M across 4 funding rounds.
Bellicum Pharmaceuticals has raised $94.2M in total across 4 funding rounds.
Bellicum Pharmaceuticals has raised $94.2M in total across 4 funding rounds.
Bellicum Pharmaceuticals's investors include AJU IB Investment, AVG Ventures, Jennison Associates, Joseph Edelman, RA Capital Management, Redmile Group, Remeditex Ventures, Ridgeback Capital Investments, Sabby Capital, James Earl "Jim" Brown III, Dennis Stone.
Bellicum Pharmaceuticals has raised $94.2M across 4 funding rounds. Most recently, it raised $55.0M Series C in August 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 27, 2014 | $55.0M Series C | AJU IB Investment, AVG Ventures, Jennison Associates, Joseph Edelman, RA Capital Management, Redmile Group, Remeditex Ventures, Ridgeback Capital Investments, Sabby Capital | |
| Jan 7, 2014 | $14.7M Series B Extension | AVG Ventures, Remeditex Ventures | |
| Mar 8, 2012 | $20.0M Series B | James Earl "Jim" Brown III, AVG Ventures, Dennis Stone | |
| Nov 2, 2009 | $4.5M Series A |